Cures Within Reach

Social Finance and Social Impact Bonds for financing rare disease research: The CWR-UK experience

In Orphan Drug Congress, Partnering & Investment by Freya SmaleLeave a Comment

“Social Finance can create new economic engines for the repurposing of generic drugs, especially for rare diseases. There are needed repurposing opportunities that can yield low profits. Governments and others have and will create incentives to motivate the creation of therapies for rare diseases.”

Dr. Bruce Bloom from Cures Within Reach joined us the World Orphan Drug Congress Europe 2015 to present on Social Finance and Social Impact Bonds for financing rare disease research: The CWR-UK experience.

Download his presentation now to find out:

  • 5 CWR Programs to Create Treatments from Drug Repurposing: CuresWithinReach, Cure Accelerator, Social Finance Initiative, The Low Profit Pharma Co. and The Generic Drug Companies Initiative
  • Social Finance Initiative
  • Creating “pay for success” repurposing economics in the UK with FindaCureand Numbers4Good
  • The Low Profit PharmaCo. – bringing low profit commercializable generic drug repurposing to market with the support of Impact Investors
  • Government Incentives – New exclusivity, voucher programs, exclusivity extension
  • Social Impact Bond Initiative
  • Social Impact Bond ROI
  • Social Impact Bond England
  • Social Impact Bond-Long Term Goal

Get your copy now >

For more information about the World Orphan Drug Congress Europe, please download their brochure >

WODC EU 2016

Leave a Comment